» Articles » PMID: 36979445

Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission

Abstract

Noradrenaline (NE) plays an integral role in shaping behavioral outcomes including anxiety/depression, fear, learning and memory, attention and shifting behavior, sleep-wake state, pain, and addiction. However, it is unclear whether dysregulation of NE release is a cause or a consequence of maladaptive orientations of these behaviors, many of which associated with psychiatric disorders. To address this question, we used a unique genetic model in which the brain-specific vesicular monoamine transporter-2 (VMAT2) gene expression was removed in NE-positive neurons disabling NE release in the entire brain. We engineered VMAT2 gene splicing and NE depletion by crossing floxed VMAT2 mice with mice expressing the Cre-recombinase under the dopamine β-hydroxylase (DBH) gene promotor. In this study, we performed a comprehensive behavioral and transcriptomic characterization of the VMAT2DBHcre KO mice to evaluate the role of central NE in behavioral modulations. We demonstrated that NE depletion induces anxiolytic and antidepressant-like effects, improves contextual fear memory, alters shifting behavior, decreases the locomotor response to amphetamine, and induces deeper sleep during the non-rapid eye movement (NREM) phase. In contrast, NE depletion did not affect spatial learning and memory, working memory, response to cocaine, and the architecture of the sleep-wake cycle. Finally, we used this model to identify genes that could be up- or down-regulated in the absence of NE release. We found an up-regulation of the synaptic vesicle glycoprotein 2c (SV2c) gene expression in several brain regions, including the locus coeruleus (LC), and were able to validate this up-regulation as a marker of vulnerability to chronic social defeat. The NE system is a complex and challenging system involved in many behavioral orientations given it brain wide distribution. In our study, we unraveled specific role of NE neurotransmission in multiple behavior and link it to molecular underpinning, opening future direction to understand NE role in health and disease.

Citing Articles

Neuroplasticity of children in autism spectrum disorder.

Chen Z, Wang X, Zhang S, Han F Front Psychiatry. 2024; 15:1362288.

PMID: 38726381 PMC: 11079289. DOI: 10.3389/fpsyt.2024.1362288.


Synaptic vesicle glycoprotein 2C enhances vesicular storage of dopamine and counters dopaminergic toxicity.

Bucher M, Dunn A, Bradner J, Egerton K, Burkett J, Johnson M Eur J Neurosci. 2024; 59(10):2483-2501.

PMID: 38532289 PMC: 11647951. DOI: 10.1111/ejn.16311.


Exploring the influence of stress on aggressive behavior and sexual function: Role of neuromodulator pathways and epigenetics.

Mbiydzenyuy N, Hemmings S, Shabangu T, Qulu-Appiah L Heliyon. 2024; 10(5):e27501.

PMID: 38486749 PMC: 10937706. DOI: 10.1016/j.heliyon.2024.e27501.

References
1.
Redrobe J, Bourin M, Colombel M, Baker G . Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berl). 1998; 138(1):1-8. DOI: 10.1007/s002130050638. View

2.
Montague P, Dayan P, Sejnowski T . A framework for mesencephalic dopamine systems based on predictive Hebbian learning. J Neurosci. 1996; 16(5):1936-47. PMC: 6578666. View

3.
Janitzky K, Lippert M, Engelhorn A, Tegtmeier J, Goldschmidt J, Heinze H . Optogenetic silencing of locus coeruleus activity in mice impairs cognitive flexibility in an attentional set-shifting task. Front Behav Neurosci. 2015; 9:286. PMC: 4631833. DOI: 10.3389/fnbeh.2015.00286. View

4.
Varemo L, Nielsen J, Nookaew I . Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res. 2013; 41(8):4378-91. PMC: 3632109. DOI: 10.1093/nar/gkt111. View

5.
Davis M, Redmond Jr D, Baraban J . Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology (Berl). 1979; 65(2):111-8. DOI: 10.1007/BF00433036. View